In human ORAI1 knock-in mice, DS-2741a inhibited T cell activation and MCs degranulation, and alleviated house dust mite–induced dermatitis, supporting the therapeutic potential of ORAI1 blockade in allergic diseases (174). Here, ORAI1 is linked to skin disorder.